These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38867543)

  • 1. Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia.
    Allen B; Savoy L; Ryabinin P; Bottomly D; Chen R; Goff B; Wang A; McWeeney SK; Zhang H
    Br J Haematol; 2024 Jul; 205(1):207-219. PubMed ID: 38867543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Naoe T
    Leuk Res; 2011 May; 35(5):685-8. PubMed ID: 21256590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
    Ullmark T; Montano G; Gullberg U
    Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia.
    Lyu X; Xin Y; Mi R; Ding J; Wang X; Hu J; Fan R; Wei X; Song Y; Zhao RY
    PLoS One; 2014; 9(3):e92470. PubMed ID: 24667279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
    Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
    J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.
    Wang XR; Chang Y; Yuan XY; Wang YZ; Qin YZ; Ruan GR; Lai YY; Liu YR
    Ann Hematol; 2020 Feb; 99(2):215-221. PubMed ID: 31900500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1.
    Potluri S; Assi SA; Chin PS; Coleman DJL; Pickin A; Moriya S; Seki N; Heidenreich O; Cockerill PN; Bonifer C
    Cell Rep; 2021 Apr; 35(3):109010. PubMed ID: 33882316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
    Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U
    Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
    Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
    Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    Gaiger A; Linnerth B; Mann G; Schmid D; Heinze G; Tisljar K; Haas OA; Gadner H; Lion T
    Eur J Haematol; 1999 Aug; 63(2):86-93. PubMed ID: 10480287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia.
    Hossain A; Nixon M; Kuo MT; Saunders GF
    J Biol Chem; 2006 Sep; 281(38):28122-30. PubMed ID: 16698800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia.
    Miglino M; Colombo N; Pica G; Grasso R; Clavio M; Bergamaschi M; Ballerini F; Ghiso A; Ghiggi C; Mitscheunig L; Beltrami G; Cagnetta A; Vignolo L; Lucchetti MV; Aquino S; Pierri I; Sessarego M; Carella AM; Gobbi M
    Leuk Lymphoma; 2011 Oct; 52(10):1961-9. PubMed ID: 21942328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.
    Siehl JM; Thiel E; Heufelder K; Snarski E; Schwartz S; Mailänder V; Keilholz U
    Br J Haematol; 2003 Oct; 123(2):235-42. PubMed ID: 14531904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
    Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U
    Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia.
    Lopotová T; Nádvorníková S; Záčková M; Polák J; Schwarz J; Klamová H; Moravcová J
    Leuk Res; 2012 Apr; 36(4):e81-3. PubMed ID: 22226711
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
    Ullmark T; Montano G; Järvstråt L; Jernmark Nilsson H; Håkansson E; Drott K; Nilsson B; Vidovic K; Gullberg U
    Biochem Biophys Res Commun; 2017 Jan; 482(4):802-807. PubMed ID: 27889611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
    Montano G; Ullmark T; Jernmark-Nilsson H; Sodaro G; Drott K; Costanzo P; Vidovic K; Gullberg U
    Leuk Res; 2016 Jan; 40():60-7. PubMed ID: 26563595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
    Mohamed AM; Balsat M; Thenoz M; Koering C; Payen-Gay L; Cheok M; Mortada H; Auboeuf D; Pinatel C; El-Hamri M; Dumontet C; Cros E; Flandrin-Gresta P; Nibourel O; Preudhomme C; Michallet M; Thomas X; Nicolini F; Solly F; Guyotat D; Campos L; Wattel E; Mortreux F
    Oncotarget; 2016 Jan; 7(3):2889-909. PubMed ID: 26284582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed mitogen-and stress-activated protein kinase 1 promotes the resistance of cytarabine in acute myeloid leukemia through brahma related gene 1-mediated upregulation of heme oxygenase-1.
    Zhang S; Pan C; Shang Q; Wang W; Hu T; Liu P; Chen S; Wang J; Fang Q
    Eur J Pharmacol; 2022 Feb; 917():174722. PubMed ID: 34953799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.